Similar articles

• Editorial comment on: Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.

  de la Rosette JJ. de la Rosette JJ. Eur Urol. 2009 Mar;55(3):647-8. doi: 10.1016/j.eururo.2008.04.092. Epub 2008 May 9. Eur Urol. 2009. PMID: 18508190 No abstract available.
• Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.

  Murat FJ, Poissonnier L, Rabilloud M, Belot A, Bouvier R, Rouviere O, Chapelon JY, Gelet A. Murat FJ, et al. Eur Urol. 2009 Mar;55(3):640-7. doi: 10.1016/j.eururo.2008.04.091. Epub 2008 May 9. Eur Urol. 2009. PMID: 18508188
• Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy.

  Kimura M, Mouraviev V, Tsivian M, Mayes JM, Satoh T, Polascik TJ. Kimura M, et al. BJU Int. 2010 Jan;105(2):191-201. doi: 10.1111/j.1464-410X.2009.08715.x. Epub 2009 Jul 2. BJU Int. 2010. PMID: 19583717 Review.
• Health-related quality of life after salvage high-intensity focused ultrasound (HIFU) treatment for locally radiorecurrent prostate cancer.

  Berge V, Baco E, Dahl AA, Karlsen SJ. Berge V, et al. Int J Urol. 2011 Sep;18(9):646-51. doi: 10.1111/j.1442-2042.2011.02815.x. Epub 2011 Jul 20. Int J Urol. 2011. PMID: 21771102
• Salvage HIFU for recurrent prostate cancer after radiotherapy.

  Chalasani V, Martinez CH, Lim D, Chin J. Chalasani V, et al. Prostate Cancer Prostatic Dis. 2009;12(2):124-9. doi: 10.1038/pcan.2008.53. Epub 2008 Oct 14. Prostate Cancer Prostatic Dis. 2009. PMID: 18852702 Review.